Mayo Clinic
200 1st Street SW
Rochester
Minnesota
55905
United States
Tel: 507-284-2511
Fax: 507-284-0161
Website: http://www.mayo.edu/
765 articles with Mayo Clinic
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded by an $11 Million U.S. Department of Defense Grant
10/10/2018
Mayo Clinic Receives $11 Million to Study TPIV110 in Combination with Trastuzumab (Herceptin®)
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S.
10/2/2018
Collaboration combines the clinical expertise of Mayo Clinic and Baxter Renal Care Services
-
ImmunogenX Completes CypCel Trial for Celiac Disease
9/27/2018
Further validation of minimally-invasive monitor of celiac villous intestinal health
-
A commercially-available medical device developed by Medtronic is helping paralyzed patients walk again.The device, which stimulates the spinal cord through electrical pulses, has been successful in helping some individuals who lost the ability to walk through injuries to their spine, regain the ...
-
September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...
9/21/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
The death of Sen. John McCain helped raise awareness about the plight of brain tumor patients and the lack of movement on developing new therapies for this disease over the past several years. But now, Houston-based Moleculin Biotech has launched a clinical trial that could be a game-changer if a...
-
Tempus Data Analytics Firm Hits $2 Billion Valuation, One of a Handful of Chicago “Unicorns”
9/5/2018
On August 29, Chicago-based Tempus, which focuses on data analytics for molecular and clinical data, announced it had raised $110 million in Series E financing. This brought total money raised so far to $320 million. This also gave the company a valuation of $2 billion. -
APEIRON EXPANDS EXECUTIVE BOARD AND APPOINTS DR. ANDERSON GAWECO AS CHIEF MEDICAL AND SCIENTIFIC OFFICER (CMSO)
8/28/2018
APEIRON Biologics AG, a biotechnology company with a broad preclinical and clinical pipeline and an approved product on the market, focusing on the discovery and development of novel cancer immunotherapies, announced today the appointment of Anderson Gaweco, M.D., Ph.D. as its Chief Medical and Scientific Officer (CMSO).
-
Accountable Care Learning Collaborative and Leading Provider Organizations Respond to Calls for Value-Based Transformation of US Health Care
8/28/2018
Today, the Accountable Care Learning Collaborative (ACLC) is pleased to release ten new Case Study Briefs (CSBs) in partnership with leading provider organizations - including Mayo Clinic, Ascension, and Montefiore Health System - each offering a concise, tactical account of a value-based solution successfully implemented.
-
According to the National Cancer Institute (NCI), pancreatic cancer is relatively rare, with about 55,440 cases diagnosed annually, representing about 3.2 percent of new cancer cases. But each year, 44,330 Americans die from the disease, or about 7.3 percent of cancer deaths.
-
Sensyne Health, a London-based healthcare artificial intelligence (AI) company founded by biotech entrepreneur Paul Drayson, recently launched an initial public offering (IPO) on the London AIM market. Drayson’s plan is to raise $78 million. It’s just one of many companies that are exploiting adv...
-
Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
8/16/2018
Elysium Health, Inc.™ has entered into an exclusive license agreement with Mayo Clinic and Harvard University.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Researchers at the Mayo Clinic, led by geneticist Fergus Couch, identified specific genes associated with triple-negative breast cancer. Triple-negative breast cancer is generally difficult to treat and has a lower five-year survival rate than other types of breast cancer.
-
A*STAR Institute and Mayo Clinic Identify Key Protein to Convert Skin Cells into Other Types of C...
7/12/2018
A*STAR’s Institute of Molecular & Cell Biology (IMCB) in Singapore, along with the Mayo Clinic, identified a key epigenetic protein called H3.3 that helps convert skin cells into other types of cells via cellular reprogramming. -
Blue Cross and Blue Shield of Minnesota and Mayo Clinic Announce New Five-Year Relationship
6/18/2018
Agreement through 2023 emphasizes high-value care, strategic collaboration
-
Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
6/5/2018
Data Presented at Digestive Disease Week Show Panel of Six Biomarkers is 95 Percent Sensitive for Most Common Type of Liver Cancer
-
Automated Breast Density from Volpara Solutions Strongly Predicts Risk of Screen-Detected and Interval Cancers
5/1/2018
Research from University of California San Francisco and the Mayo Clinic Supports the Use of Fully Automated Volpara®Density™ Software to Inform Women of their Breast Density